Glaukos Technologies Featured in Numerous Scientific Abstrac

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today... | May 1, 2023

Related Keywords

United States , San Diego , California , American , Transepithelial Cross , Ashraf Armia Balamoun , Williamb Trattler , Johnp Berdahl , Interno Canaloplasty , Miltos Balidis , Miltiadis Balidis , Xiongfei Liu , Philip Dockery , Kennetha Beckman , Brendang Cronin , Ikek Ahmed , Mitchellc Shultz , Julia Yu , Tannerj Ferguson , Miguel Rechichi , Markj Gallardo , Steven Greenstein , Glaukos Corporation , Key Corneal Health Presentations , Key Corneal Health Course , Key Corneal Health Posters , American Society Of Cataract , American Society , Refractive Surgery , Glaucoma Presentations , Year Glaucoma Control , Second Generation Trabecular Micro Bypass , Cataract Surgery , Uncontrolled Glaucoma , Ab Interno Canaloplasty , Moderate Open Angle Glaucoma , Ticiana De Francesco , Term Endothelial Safety , Generation Trabecular Micro Bypass , Open Angle Glaucoma , Glaucoma Posters , Trabecular Micro Bypass Stent Implantation , Cataract Extraction , Long Term Results , Blade Goniotomy , Potentiate Aqueous Outflow , Reduce Intraocular Pressure , Combined Phacoemulsification , South East Asian Eyes , Combining Two , Mild To Moderate Glaucoma , Corneal Health Presentations , Year Results , Accelerated Epi O , Corneal Cross Linking , Progressive Keratoconus , Year Follow Up , Collagen Cross Linking , Subsequent Topography Altering Surgery , Corneal Swelling , Corneal Collagen Cross Linking , Progressive Keratoconus Patients , Transepithelial Cross Linking , Thin Corneas , Corneal Health Posters , Topography Guided Epi On Corneal Cross Linking , Pulsed Irradiation , Corneal Health Course , New Cutting Edge Treatments , Corneal Ectasia , Micro Invasive Glaucoma Surgery , Sturge Weber Syndrome , Glaukos Corporation Stock Exchange , News , Information , Press Release , Glaukos , Corporation , N , Ophthalmic , Medical , Technology , End , Harmaceutical , Company , Ocused , Novel , Therapies , Or , The , Treatment , F , Corneal , Disorders , Retinal , Nnounced Gkos Us3773221029 ,